Top 10 Companies in the High Shear Granulator Pharmaceutical Wet Mass End Point Market (2026): Market Leaders Powering Global Pharmaceutical Manufacturing

MARKET INSIGHTS

Global High Shear Granulator Pharmaceutical Wet Mass End Point market size was valued at USD 387.6 million in 2025. The market is projected to grow from USD 412.4 million in 2026 to USD 734.8 million by 2034, exhibiting a CAGR of 7.5% during the forecast period.

High shear granulator pharmaceutical wet mass end point refers to the critical process parameter in wet granulation where the granular mass reaches an optimal consistency, density, and moisture content before proceeding to the drying stage. This end point determination is essential in solid dosage form manufacturing, as it directly influences the quality, compressibility, and flowability of the final granules. The technology encompasses a range of detection methodologies, including power consumption monitoring, torque measurement, near‑infrared (NIR) spectroscopy, and acoustic emission techniques, all deployed within high shear granulator systems to ensure batch‑to‑batch reproducibility and regulatory compliance.

The market is witnessing steady growth driven by the increasing demand for oral solid dosage forms, tightening regulatory requirements around process analytical technology (PAT), and the pharmaceutical industry’s broader shift toward continuous manufacturing and real‑time quality assurance. Leading equipment manufacturers such as GEA Group, Syntegon Technology, and L.B. Bohle continue to advance integrated end point detection solutions, reinforcing market momentum across both established and emerging pharmaceutical manufacturing hubs.

High Shear Granulator Pharmaceutical Wet Mass End Point Market – View in Detailed Research Report

10. GEA Group AG

Headquarters: Düsseldorf, Germany
Key Offering: Integrated PAT‑enabled high shear granulators with torque and power consumption monitoring, NIR spectroscopy modules, and digital twin integration.

GEA Group has been a pioneer in pharmaceutical equipment engineering, delivering high‑performance granulation solutions that meet stringent FDA and EMA requirements. Their latest line of high shear granulators incorporates real‑time end point detection, enabling manufacturers to reduce over‑granulation incidents and improve batch acceptance rates.

Sustainability & Growth Initiatives:

• Investment in Industry 4.0 connectivity and cloud‑based analytics.
• Partnerships with leading pharmaceutical companies to validate PAT‑based end point models.
• Expansion of service networks across North America, Europe, and Asia‑Pacific.

9. Glatt GmbH

Headquarters: Erlangen, Germany
Key Offering: Compact high shear granulators with integrated torque sensors and acoustic emission detection for precise wet mass end point.

Glatt’s solutions are widely adopted in both R&D and full‑scale production environments, providing robust end point monitoring that aligns with QbD and continuous manufacturing strategies.

Sustainability & Growth Initiatives:

• Development of low‑energy consumption granulation systems.
• Collaboration with regulatory agencies to streamline PAT validation.
• Expansion of digital training programs for operators.

8. Romaco Group

Headquarters: Mühlheim am Main, Germany
Key Offering: High‑shear granulators with integrated NIR spectroscopy and torque monitoring, tailored for controlled release formulations.

Romaco’s platforms are known for their precision and scalability, enabling manufacturers to meet complex formulation requirements.

Sustainability & Growth Initiatives:

• Investment in renewable energy for manufacturing facilities.
• Research into biodegradable excipients.
• Digital twin technology for process simulation.

7. L.B. Bohle Maschinen und Verfahren GmbH

Headquarters: Lübbecke, Germany
Key Offering: High‑shear granulators with advanced torque and power consumption monitoring, integrated with cloud‑based PAT platforms.

Their solutions provide real‑time data analytics, supporting continuous manufacturing and regulatory compliance.

Sustainability & Growth Initiatives:

• Development of energy‑efficient motor drives.
• Partnerships with academic institutions for AI‑based end point prediction.
• Implementation of circular manufacturing practices.

6. Collette (Getinge Group)

Headquarters: Brussels, Belgium
Key Offering: High‑shear granulators with integrated PAT sensors, including torque, power, and NIR modules.

Collette’s equipment is widely used in European pharmaceutical facilities, offering reliable end point detection and robust data integration.

Sustainability & Growth Initiatives:

• Focus on reducing water consumption in granulation processes.
• Deployment of predictive maintenance systems.
• Expansion of service and support networks in emerging markets.

5. Sejong Pharmatech Co., Ltd.

Headquarters: Seoul, South Korea
Key Offering: High‑shear granulators with integrated torque and NIR sensors for rapid end point determination.

Sejong Pharmatech’s platforms are tailored for the Korean and broader Asia‑Pacific market, supporting rapid scale‑up and compliance with local regulations.

Sustainability & Growth Initiatives:

• Investment in smart factory solutions.
• Collaboration with Korean regulatory agencies for PAT validation.
• Development of low‑emission equipment.

4. Anchor Mark Private Limited

Headquarters: Mumbai, India
Key Offering: Cost‑effective high‑shear granulators with integrated torque monitoring and power consumption analysis.

Anchor Mark’s solutions are popular among generic manufacturers in India, providing reliable end point detection at an affordable price point.

Sustainability & Growth Initiatives:

• Local manufacturing to reduce supply chain carbon footprint.
• Training programs for operators on PAT implementation.
• Expansion of after‑sales support in Tier‑2 cities.

3. Prism Pharma Machinery

Headquarters: Pune, India
Key Offering: High‑shear granulators with integrated torque and power sensors, designed for rapid deployment in CDMO facilities.

Prism Pharma’s platforms are known for their modularity and ease of integration with existing manufacturing lines.

Sustainability & Growth Initiatives:

• Development of energy‑efficient motors.
• Partnerships with Indian universities for AI‑based end point modeling.
• Deployment of predictive analytics dashboards.

2. DIOSNA Dierks & Söhne GmbH

Headquarters: Biberach, Germany
Key Offering: High‑shear granulators with advanced acoustic emission detection and torque monitoring for precise wet mass end point.

DIOSNA’s equipment is widely used in European pharmaceutical facilities, offering high reliability and data integrity.

Sustainability & Growth Initiatives:

• Investment in low‑noise motor designs.
• Collaboration with regulatory bodies for PAT validation.
• Digital twin integration for process optimization.

1. Kevin Process Technologies Pvt. Ltd.

Headquarters: Hyderabad, India
Key Offering: High‑shear granulators with integrated torque, power consumption, and NIR modules, tailored for the Indian market.

Kevin Process Technologies provides affordable, scalable solutions that meet stringent regulatory standards, making them a preferred choice for emerging CDMOs.

Sustainability & Growth Initiatives:

• Local manufacturing to reduce logistics emissions.
• Training and certification programs for operators.
• Partnerships with Indian regulatory agencies for PAT harmonization.

High Shear Granulator Pharmaceutical Wet Mass End Point Market – View in Detailed Research Report

High Shear Granulator Pharmaceutical Wet Mass End Point Market – View in Detailed Research Report

Market Outlook

The High Shear Granulator Pharmaceutical Wet Mass End Point market is set to expand at a CAGR of 7.5% from USD 412.4 million in 2026 to USD 734.8 million by 2034. Growth will be driven by the global shift toward continuous manufacturing, increasing demand for oral solid dosage forms, and the adoption of PAT frameworks that mandate real‑time end point monitoring. Emerging markets, particularly India and China, will contribute significantly to new installations, while established players will focus on retrofitting legacy lines with advanced detection technologies.

Future Trends

Key future trends include the integration of artificial intelligence and machine learning for predictive end point determination, the adoption of digital twins for process simulation, and the expansion of Industry 4.0 connectivity to enable closed‑loop granulation control. Regulatory emphasis on QbD and real‑time release testing will further accelerate the deployment of integrated PAT‑enabled granulation systems. Additionally, sustainability initiatives such as energy‑efficient motors, reduced water usage, and circular manufacturing practices will become critical differentiators for market leaders.